Holen Sie sich die Stockscreener-App
7.00
0.14%
0.010
Handel nachbörslich:
7.00
Schlusskurs vom Vortag:
$6.99
Offen:
$6.9
24-Stunden-Volumen:
406.95K
Relative Volume:
1.35
Marktkapitalisierung:
$395.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-72.89M
KGV:
-2.8926
EPS:
-2.42
Netto-Cashflow:
$-68.47M
1W Leistung:
+7.20%
1M Leistung:
+1.60%
6M Leistung:
+12.72%
1J Leistung:
-39.13%
1-Tages-Spanne:
$6.5005
$7.15
1-Wochen-Bereich:
$6.09
$7.15
52-Wochen-Spanne:
$3.555
$12.92
Astria Therapeutics Inc Stock (ATXS) Company Profile
Firmenname
Astria Therapeutics Inc
Sektor
Branche
Telefon
617-349-1971
Adresse
22 BOSTON WHARF ROAD, BOSTON
Vergleichen Sie ATXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATXS
Astria Therapeutics Inc
|
7.00 | 371.91M | 0 | -72.89M | -68.47M | -2.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Astria Therapeutics Inc Stock (ATXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-01-31 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-07-29 | Eingeleitet | TD Cowen | Buy |
| 2023-03-28 | Eingeleitet | Evercore ISI | Outperform |
Astria Therapeutics Inc Aktie (ATXS) Neueste Nachrichten
Astria Therapeutics’ Strategic Use of Equity Incentives: A Catalyst for Talent Retention and Innovation in a High-Stakes Biotech Landscape? - AInvest
Astria Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Does Astria Therapeutics Inc. have strong EBITDA marginsQuarterly Investment Review & Accurate Intraday Trading Signals - khodrobank.com
Astria Therapeutics shares rise 3.26% intraday after announcing Phase 1a trial data presentation at EADV Congress 2025. - AInvest
Astria Therapeutics to present STAR-0310 phase 1a data at EADV congress - Investing.com
Astria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025 - Yahoo Finance
Has Astria Therapeutics Inc. formed a bullish divergenceWeekly Trade Analysis & Scalable Portfolio Growth Ideas - Newser
Will Astria Therapeutics Inc. outperform its industry peersWeekly Profit Report & Real-Time Volume Analysis - khodrobank.com
Can Astria Therapeutics Inc. disrupt its industryCEO Change & Fast Exit Strategy with Risk Control - khodrobank.com
Astria Therapeutics Inc. stock volume spike explainedPortfolio Update Summary & Entry Point Strategy Guides - Newser
What machine learning models say about Astria Therapeutics Inc.July 2025 Decliners & Weekly Top Performers Watchlists - Newser
Technical analysis overview for Astria Therapeutics Inc. stockJuly 2025 Setups & Verified Technical Signals - Newser
Visual trend scoring systems applied to Astria Therapeutics Inc.2025 Trading Volume Trends & Risk Managed Trade Strategies - Newser
What does recent volatility data suggest for Astria Therapeutics Inc.Earnings Risk Summary & Real-Time Price Movement Reports - Newser
Key metrics from Astria Therapeutics Inc.’s quarterly dataWall Street Watch & Expert Curated Trade Setups - Newser
Is Astria Therapeutics Inc. stock poised for growth2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - Newser
Is Astria Therapeutics Inc. forming a bottoming baseQuarterly Portfolio Summary & Intraday High Probability Alerts - Newser
Astria Therapeutics Inc. stock trend forecastJuly 2025 Sentiment & Accurate Buy Signal Notifications - Newser
What to expect from Astria Therapeutics Inc. in the next 30 days2025 Volatility Report & Smart Money Movement Alerts - Newser
What earnings revisions data tells us about Astria Therapeutics Inc.July 2025 Outlook & Real-Time Stock Price Movement Reports - Newser
Detecting support and resistance levels for Astria Therapeutics Inc.Volume Spike & Community Trade Idea Sharing - Newser
What machine learning models say about Astria Therapeutics IncEarnings Growth Report & Weekly Breakout Stock Alerts - Newser
Visual trend scoring systems applied to Astria Therapeutics IncWall Street Watch & Weekly Top Gainers Trade List - Newser
Applying Elliott Wave Theory to Astria Therapeutics Inc.Market Performance Report & High Accuracy Trade Alerts - Newser
Will Astria Therapeutics Inc. continue its uptrend2025 Pullback Review & Daily Stock Trend Reports - Newser
Astria Therapeutics Inc. stock momentum explainedPortfolio Risk Summary & Daily Entry Point Alerts - Newser
Astria Therapeutics Inc. stock daily chart insightsWeekly Trade Analysis & High Accuracy Swing Entry Alerts - Newser
Order flow analysis tools used on Astria Therapeutics Inc.July 2025 Rallies & Detailed Earnings Play Strategies - Newser
Is Astria Therapeutics Inc. stock ready for a breakout2025 Dividend Review & Scalable Portfolio Growth Ideas - Newser
Forecasting Astria Therapeutics Inc. price range with options data2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - Newser
Finanzdaten der Astria Therapeutics Inc-Aktie (ATXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):